Ion crosslinking [142] |
Interaction between crosslinking agent and the amino or carboxyl groups of chitosan NPs. |
The preparation process itself has no organic solvent; the reaction conditions are simple, mild, and controllable. |
Not completely immune to gastric acid degradation; low solubility. |
Polyelectrolyte complexation [143,144] |
Interactions between oppositely charged polyelectrolytes. |
Two- or three-step process; the equipment requirements are not demanding, and the conditions are mild. |
Stability is susceptible to pH. |
Desolvation [145] |
Insolubility of chitosan in alkaline media. |
High nanoparticle formation rate; improved physical stability. |
Inhomogeneous distribution of NPs; difficulty in synthesizing smaller-sized chitosan NPs. |
Emulsification [146,147,148,149,150] |
The oil and water phases are emulsified; then, the solvent is removed. |
Two- to three-step process; no need for sonication or homogenizers. |
Causes significant toxicity to tissues or cells; poor stability. |
Spray drying [151,152] |
Amino groups can be protonated by acids. |
Re-dispersibility; enables easier synthesis of smaller sizes compared other methods; low toxicity. |
The particle size is not easy to control; the particles are irregularly shaped and sticky. |
Covalent crosslinking [153,154] |
Formation of covalent bonds between chitosan NPs and crosslinking agents. |
Controllable drug release. |
Cytotoxic. |
Reverse micelle [153,155] |
Trans-interaction between chitosan NPs and crosslinking agent. |
One-step process; good dispersion. |
Causes significant toxicity in tissues or cells. |